Eli Lilly ovarian drug gets FDA Breakthrough status
INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted...
Novartis’ ianalumab receives FDA Breakthrough Therapy designation for Sjögren’s disease
Novartis has announced that ianalumab has received Breakthrough Therapy designation from the US FDA to treat Sjögren’s disease.
Sjögren’s disease is a progressive autoimmune condition....
Breakthrough in Hospitalized COVID-19 Treatment
In a significant advance for COVID-19 treatment, recent findings emerged from the double-blind randomized placebo-controlled COMCOVID trial, which evaluated the efficacy of Tiprelestat in...
New blood test cited as potential major breakthrough in breast cancer...
Fox News senior medical analyst Dr. Marc Siegel joins ‘Fox & Friends’ to discuss a new study on breast cancer treatment and Matt Damon’s...
Scientists make breakthrough that could transform bowel and liver cancer treatment
Researchers at Cancer Research UK Scotland Institute have discovered a protein that could lead to new treatments for certain bowel and liver cancers by...
Scientists make bowel and liver cancer treatment breakthrough
Scientists make bowel and liver cancer treatment breakthrough
Source link
Revolutionizing Pancreatic Cancer: Immunology and Therapy Breakthroughs
Pancreatic cancer remains one of the most aggressive malignancies globally, with a historically poor prognosis and limited therapeutic options. Recent advancements in the understanding...
New Colorectal Cancer Treatments at MSK Aim To Reduce Deaths in...
Colorectal cancer, which includes cancer of both the colon and the rectum, is the third most common cancer in both men and women in the United...
Five-year cancer survival rates hit 70% as doctors credit screening, treatment...
RALEIGH, N.C. (WTVD) -- The American Cancer Society reports that the five-year relative cancer survival rate for all cancers combined hit 70% for people...


































